Pathway Medical Technologies, the Kirkland, WA-based developer of a medical device to clear out blockages in leg arteries, said today it has received regulatory clearance to sell the product in Europe. The company is now developing plans to sell the Jetstream G2 NXT for peripheral artery disease in all European Union countries. The product first won FDA approval in July 2008.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
